Obstructive vs Restrictive Pulmonary Disease

Obstructive and restrictive lung diseases are groups of conditions affecting ventilation, which is the mechanical movement of inhalation, an exhalation that moves air in and out of the lungs.

So gas exchange can occur obstructive lung diseases are characterized by obstruction of exhalation, causing air to be trapped within the lungs.

Whereas restrictive lung diseases restrict inhalation, preventing the lungs from filling with adequate amounts of oxygen rich air.

So the primary role of the lungs is facilitating gas exchange between the external environment and the circulatory system.

And a key step in this process is ventilation. During the inhalation phase of ventilation.

The respiratory muscles, primarily the diaphragm and the external intercostal muscles contract the diaphragm moves downward and flattens.

While external intercostal muscles cause the ribcage to expand, increasing the volume of the chest cavity. This creates pressure in the lungs thats lower than atmospheric pressure, allowing oxygen rich air to move in and fill the lungs.

Then during exhalation, the respiratory muscles relax and the lungs return to their resting state. This creates pressure in the lungs that's higher than the atmospheric pressure, allowing air to move out of the lungs.

Now, there are some crucial factors that support the process of ventilation. First, there's the ability of the lungs to expand and fill during inhalation, which is called compliance.

Lung compliance is determined by other factors like the presence of elastin fibers within the lung tissue and the ability of the chest wall to expand and contract during ventilation.

Compliance is also dependent on the surface tension within the alveoli, which are the tiny sacks where gas exchange happens.

The alveoli are lined with a thin film of water which creates a force called surface tension that tends to collapse the alveoli to counteract this certain cells within the alveolar walls.

Called type two pneumocytes produce surfactant, which is a lipoprotein that lines the alveolar walls reduces surface tension, prevents the alveoli from collapsing and allows them to easily expand and contract during ventilation.

Then after the lungs have expanded elastic recoil, which is the tendency of the lungs and the chest wall to passively return to their resting state, facilitates exhalation.

Another factor thats important in ventilation is airway resistance, which is the resistance in the respiratory tract to the flow of air.

Normally resistance in the airways such as the trachea, bronchi and bronchioles is low and they easily expand along with the lungs during inhalation and then return to their resting state during exhalation factors affecting airway resistance include the bronchial smooth muscle which controls the diameter of the airways and mucociliary clearance.

The process where mucus produced by goblet cells trap bacteria and inhaled particles. While the ciliated epithelium moves the mucus upward and out of the respiratory tract.

When there are alterations in the muscles of respiration, lung compliance, elastic recoil or airway resistance can obstruct or restrict ventilation and increase the work of breathing needed for oxygen to reach the alveoli.

So, gas exchange can occur. Now after ventilation, the next step needed for gas exchange is perfusion, which is the flow of blood through the pulmonary system.

So, gasses can move between the alveoli and the circulatory system. This is measured by the VQ ratio that represents the relationship between ventilation or v and quantity of perfusion or Q.

When both ventilation and perfusion are optimal, the ratio between them is matched and gas exchange is effective poor oxygenation from impaired ventilation is represented by a VQ mismatch where there's either a low VQ ratio, meaning there's less oxygen available for the blood to pick up or a high VQ ratio, which means there's more air in the lungs than available blood flow.

Ok. So conditions that impair ventilation can cause obstructive and restrictive lung diseases.

Examples of obstructive lung diseases include asthma, chronic bronchitis and emphysema. While examples of restrictive lung diseases include pulmonary fibrosis, atelectasis and chest wall deformities.

Risk factors include exposure to tobacco smoke, air pollution irritants such as fumes or vapors and allergens like dust, recurrent respiratory infections and genetics and family history.

Now, obstructive lung diseases are characterized by obstruction of airflow during exhalation. So, emptying the lungs of air is impaired.

For instance, in asthma, inflammation leads to increased airway resistance due to hyper responsive airways, increased bronchial smooth muscle contraction, thickening of the airway walls and increased mucus production, airflow is obstructed.

So it's difficult to move air in and out of the lungs. Likewise, chronic bronchitis is characterized by an accumulation of mucus bronchial edema and airway trapping where air remains in the lungs.

After exhalation lastly, in emphysema, lung tissue is damaged and becomes loose and inelastic. This impairs elastic recoil.

So it doesn't spring back after inhalation, damaged, alveoli also lose their elasticity. So they become enlarged and collapse during exhalation.

In contrast, in restrictive lung diseases, air doesn't easily enter the lungs during inhalation leading to a reduced lung volume.

So, in pulmonary fibrosis, inflammation and scarring causes connective tissues within the lungs to become fibrous, resulting in stiff lungs with decreased compliance.

So, more inspiratory effort is needed with atelectasis. The partial collapse of lung tissue and decreased surfactant makes the lungs less compliant and more difficult to expand during inhalation.

And lastly, chest wall compliance can be decreased with deformities like kyphoscoliosis that can structurally restrict lung expansion.

Clinical manifestations of obstructive and restrictive lung diseases are related to impaired airflow with additional signs and symptoms depending on the underlying cause.

Generally, they present with dyspnea, increased work of breathing and hypoxemia. Other clinical manifestations can be seen by measuring the volumes and flow rates of air that moves in and out of the lungs, using pulmonary function tests or PFTs in obstructive lung disease, emptying of the lungs is slow.

So there's an increase in the functional residual capacity or FRC, which is the amount of air remaining in the lungs at the end of a normal exhalation and an increase in the residual volume or RV, which is the amount of air left in the lungs after exhaling as hard as possible.

There's also a significant reduction in the forced expiratory volume in one second or FEV one, which measures the amount of air that can be forcibly exhaled in the 1st 2nd of a maximum exhalation after a deep breath.

On the other hand, in restrictive lung disease, where inhalation is more difficult and lung volumes are reduced, there's a decrease in total lung capacity or TLC.

There's also a decrease in the FRC, the RV and the FEV. One finally, because perfusion is adequate in obstructive and restrictive lung diseases, but the ventilation isn't a VQ mismatch will be present.

In this case, a low VQ ratio. This will ultimately cause hypoxemia or low blood oxygen levels.

All right. As a quick recap, obstructive and restrictive lung diseases are two groups of conditions that affect movement of air in or out of the lungs.

General clinical manifestations are related to impaired airflow and can include dyspnea, increased work of breathing and hypoxemia